Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Financial planning involves a series of steps to help you achieve your financial goals. Learn more about the process and how to start.
19,593 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Unexpected bills hit hard, even for budget-focused savers. This guide explains why having emergency fund beats raidin...
Nu Holdings faced a sharp February drop as U.S. expansion uncertainty and broader macro headwinds collided with stron...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
Rivian's upcoming R2 could expand its market appeal far beyond premium EVs. This article breaks down why investors ma...
A provocative SXSW moment spurred a wave of Gen Z investing chatter, with young traders leaning into memes, predictio...
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
In San Francisco, activists and industry critics gathered outside AI hubs to demand a pause on fast-paced development...
Oil traders are weighing a hypothetical '$200 trump radar' scenario as prices approach extreme levels. This report ex...
Is Bitcoin really the better store value: bitcoin option, or do gold-backed stablecoins offer a compelling alternativ...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...